Translational glycobiology: from bench to bedside-Reference-Cited by-同舟云学术

Translational glycobiology: from bench to bedside

Published:2019-09-17 Issue:10 Volume:112 Page:424-427
ISSN:0141-0768
Container-title:Journal of the Royal Society of Medicine
language:en
Short-container-title:J R Soc Med

Author:

Axford John¹,Alavi Azita¹^ORCID,Cummings Rick²,Lauc Gordan³,Opdenakker Ghislain⁴,Reis Celso⁵,Rudd Pauline⁶

Affiliation:

1. The Molecular and Clinical Sciences Research Institute, St George’s University of London, London SW17 0RE, UK

2. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston 02115, USA

3. Faculty of Pharmacy and Biochemistry, University of Zagreb, HR-10000 Zagreb, Croatia

4. Department of Microbiology and Immunology, University of Leuven, KU Leuven, BE-3000 Leuven, Belgium

5. Institute of Molecular Pathology and Immunology, University of Porto, 4200-135 Porto, Portugal

6. National Institute for Bioprocessing Research and Training, Dublin A94 X099, Ireland

Abstract

The importance of sugars to protein function is real and is of significant clinical relevance. Technology advances enable large population studies to be carried out, shedding light on individual sugar variation and variations with time. Three-dimensional mass spectroscopy on solid pathological specimens is going to open up a whole new world of pathology visualisation. The door is now open to exploit carbohydrate recognition in new therapeutics by identifying novel biomarkers in cancer to aid diagnosis, and also providing therapeutic targets for treatment. Glycan age correlates with biological age. This means we can map the reversal of biological age with exercise and diet.

Publisher

SAGE Publications

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/0141076819865863

Reference28 articles.

1. Mechanisms of disease: The human N-glycome

2. Glycans Are a Novel Biomarker of Chronological and Biological Ages

3. Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults

4. Genomics Meets Glycomics—The First GWAS Study of Human N-Glycome Identifies HNF1α as a Master Regulator of Plasma Protein Fucosylation

5. Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of plasma collection tubes on N-glycome in human blood samples;Practical Laboratory Medicine;2024-03

3. Glycopeptide database search and de novo sequencing with PEAKS GlycanFinder enable highly sensitive glycoproteomics;Nature Communications;2023-07-08

4. The Role of Clinical Glyco(proteo)mics in Precision Medicine;Molecular & Cellular Proteomics;2023-06

5. Glycoproteomics;Nature Reviews Methods Primers;2022-06-23